MusclePharm Corporation (OTCMKTS:MSLP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 16, 2017, MusclePharm Corporation (the “Company”) announced that, effective as of such date, Mr. Peter Lynch left the Company. The Company is currently negotiating a separation agreement with Mr. Lynch. Mr. Douglas West, V.P. of Finance and Administration will serve as our interim Principal Financial Officer and interim Principal Accounting Officer.

About MusclePharm Corporation (OTCMKTS:MSLP)

MusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company’s portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman’s lifestyle utilizing ingredients that cover the range of busy women’s needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil.

MusclePharm Corporation (OTCMKTS:MSLP) Recent Trading Information

MusclePharm Corporation (OTCMKTS:MSLP) closed its last trading session 00.00 at 2.05 with 20,522 shares trading hands.